Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations are supplied, so the description carries the full disclosure burden, and it does deliver two useful behavioral facts beyond the schema: a coverage limitation (US-listed preferred) and a billing consequence ('counts as one conversation against your PickSkill plan'), which functions as a cost/rate signal. It does not state that the operation is read-only, how stale the underlying earnings data may be, or what happens for a ticker with no recent release. Good on cost, thin on failure modes.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The payload description is front-loaded in the first sentence, with the caveat and the cost note following as short, purposeful addenda. Nothing is padded or redundant. A slightly tighter phrasing could fold the coverage note into the opening sentence, but the current structure is efficient.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema and no annotations, the description must describe returns itself, and it does so by enumerating the returned categories (report date, EPS actual vs. estimate, surprise, and five ratio families). That is sufficient for an agent to know what it will get from a read-only lookup. The remaining gaps are the US-listing tension with the schema's other exchange examples and unstated behavior for tickers lacking recent earnings.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

There is a single required parameter at 100% schema coverage, and the schema already documents Yahoo Finance ticker formats across US, Hong Kong, Shanghai, and Shenzhen exchanges. The description adds only the loose 'US-listed' preference, which slightly conflicts in tone with the schema's multi-market examples but does not explain the discrepancy. The schema does the heavy lifting, so baseline 3 applies.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description names a specific resource and its contents: the latest earnings release (report date, actual vs. estimated EPS, surprise) plus key financial ratios (valuation, margins, ROE, leverage, growth). That enumeration is concrete enough that an agent can distinguish it from get_my_portfolio and get_stock_signals without opening a schema. It stops short of a 5 because it never explicitly contrasts itself with those siblings.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

The clause 'Best for US-listed stocks' gives a real scoping hint about when this tool fits and where coverage degrades. However, there is no statement of when not to use it, no guidance for non-US tickers, and no routing to the sibling tools for portfolio-wide or signal-oriented questions. Usage is implied rather than directed.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.